Troyen Brennan - Feb 3, 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Chief Medical Officer
Signature
/s/ Troyen Brennan
Stock symbol
CVS
Transactions as of
Feb 3, 2022
Transactions value $
-$371,032
Form type
4
Date filed
2/4/2022, 03:46 PM
Previous filing
Nov 3, 2021
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Options Exercise $4.9M +47.9K +34.68% $102.26 186K Feb 3, 2022 Direct
transaction CVS Common Stock Sale -$5.27M -47.9K -25.75% $110.00 138K Feb 3, 2022 Direct F1
holding CVS Common Stock (restricted) 4.81K Feb 3, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -47.9K -100% $0.00* 0 Feb 3, 2022 Common Stock 47.9K $102.26 Direct F2
holding CVS Stock Option 53.8K Feb 3, 2022 Common Stock 53.8K $104.82 Direct F3
holding CVS Stock Option 75.1K Feb 3, 2022 Common Stock 75.1K $78.05 Direct F4
holding CVS Stock Option 21.9K Feb 3, 2022 Common Stock 21.9K $62.21 Direct F5
holding CVS Stock Option 80.8K Feb 3, 2022 Common Stock 80.8K $54.19 Direct F6
holding CVS Stock Option 84.5K Feb 3, 2022 Common Stock 84.5K $58.34 Direct F7, F8
holding CVS Stock Option 99.3K Feb 3, 2022 Common Stock 99.3K $74.30 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Option became exercisable in four equal annual installments, commencing 4/1/2016.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F4 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7 The number of shares subject to the option were calculated using a 30-day average price.
F8 Options became exercisable in four equal annual installments, commencing 4/1/2021.
F9 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.